Back to Agenda
S5 - Bridging Regulation and Reality: Decentralized Trials for Broader Participation
Session Chair(s)
Kyung-Sang Yu, MD, PHD, MBA
Professor, Seoul National University College of Medicine and Hospital, Korea, Republic of
Amy (Hyunjoo) Lee, MBA, RPH
Executive Director, Country Research Director, MSD Korea Ltd., Korea, Republic of
Speaker(s)
Jun Gi Hwang, MD, PHD
Associate Professor,, Chungbuk National University College of Medicine and Hospital, Korea, Republic of
DCT Recommendations and Guidelines
Yoonjin Kim, MD
Department of Clinical Pharmacology and Therapeutics, Seoul National University, Korea, Republic of
Ensuring Data Integrity in Decentralized Clinical Trials - Strategic Integration of Personal Health Records
Mikiko Kubo
Inspector, Office of Non-Clinical and Clinical Compliance, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Decentralized Clinical Trials - Implementation and Insight in Japan (PMDA Experience)
Yoomin Song
Clinical Research Lead, Eli Lilly and Company, Korea, Republic of
Hyun Bae
Associate Director, Clinical Research Manager (CRM), MSD Korea Ltd., Korea, Republic of
OkSun Im
Local Head of CD&O, HP, Boehringer Ingelheim Korea Ltd., Korea, Republic of
Stella Ha
Sr. Director, Clinical Operations Korea, Gilead Sciences, Korea, Republic of
Have an account?